Prognostic Indicators Following Ipsilateral Tumor Recurrence in Patients Treated with Breast-conserving Therapy

Overview

Journal Am J Surg

Specialty General Surgery

Date 2009 Oct 6

PMID 19800468

Citations 1

Authors

Richard Tuli

John Christodouleas

Leah Roberts

Sharon J Deol

Kenneth Y Usuki

Deborah Frassica

Anne L Rosenberg

Affiliations

Soon will be listed here.

Abstract

Background: We attempt to determine significant predictors of systemic recurrence following ipsilateral breast tumor recurrence (IBTR).

Methods: A retrospective single-institution chart review of all newly diagnosed breast cancer patients was conducted to identify women treated with breast-conserving therapy (BCT) who developed IBTR. Charts were reviewed for demographics, clinical presentation, method of detection, stage, type of therapy, histopathology, and margin status for both the primary and recurrent tumors.

Results: Of 1,733 patients who were treated with BCT, 157 experienced IBTR. Multivariate Cox regression showed that time to recurrence and method of detection of local recurrence remained significant predictors of distant metastases-free survival (DMFS). Median DMFS times for clinically and radiographically detected IBTRs were 54 months and 231 months, respectively. Adjusted relative risk for clinically detected IBTRs was 2.2.

Conclusions: Given the prognostic significance of post-treatment mammography in our study, combined with median time to recurrence of 44 months, we believe that routine long-term mammographic surveillance is indicated following BCT.

Citing Articles

Do all patients require radiotherapy after breast-conserving surgery?.

Skandarajah A, Mann G Cancers (Basel). 2013; 2(2):740-51.

PMID: 24281092 PMC: 3835102. DOI: 10.3390/cancers2020740.

References

Komoike Y, Akiyama F, Iino Y, Ikeda T, Akashi-Tanaka S, Ohsumi S . Ipsilateral breast tumor recurrence (IBTR) after breast-conserving treatment for early breast cancer: risk factors and impact on distant metastases. Cancer. 2005; 106(1):35-41. DOI: 10.1002/cncr.21551. View

van Dongen J, Bartelink H, Fentiman I, Lerut T, Mignolet F, Olthuis G . Factors influencing local relapse and survival and results of salvage treatment after breast-conserving therapy in operable breast cancer: EORTC trial 10801, breast conservation compared with mastectomy in TNM stage I and II breast cancer. Eur J Cancer. 1992; 28A(4-5):801-5. DOI: 10.1016/0959-8049(92)90118-l. View

Montgomery D, Krupa K, Cooke T . Follow-up in breast cancer: does routine clinical examination improve outcome? A systematic review of the literature. Br J Cancer. 2007; 97(12):1632-41. PMC: 2360278. DOI: 10.1038/sj.bjc.6604065. View

Veronesi U, Marubini E, Del Vecchio M, Manzari A, Andreola S, Greco M . Local recurrences and distant metastases after conservative breast cancer treatments: partly independent events. J Natl Cancer Inst. 1995; 87(1):19-27. DOI: 10.1093/jnci/87.1.19. View

Shen J, Hunt K, Mirza N, Buchholz T, Babiera G, Kuerer H . Predictors of systemic recurrence and disease-specific survival after ipsilateral breast tumor recurrence. Cancer. 2005; 104(3):479-90. DOI: 10.1002/cncr.21224. View

Doyle T, Schultz D, Peters C, Harris E, Solin L . Long-term results of local recurrence after breast conservation treatment for invasive breast cancer. Int J Radiat Oncol Biol Phys. 2001; 51(1):74-80. DOI: 10.1016/s0360-3016(01)01625-x. View

Doubeni C, Field T, Yood M, Rolnick S, Quessenberry C, Fouayzi H . Patterns and predictors of mammography utilization among breast cancer survivors. Cancer. 2006; 106(11):2482-8. DOI: 10.1002/cncr.21893. View

Haffty B, Reiss M, Beinfield M, Fischer D, Ward B, MCKHANN C . Ipsilateral breast tumor recurrence as a predictor of distant disease: implications for systemic therapy at the time of local relapse. J Clin Oncol. 1996; 14(1):52-7. DOI: 10.1200/JCO.1996.14.1.52. View

Pinsky R, Rebner M, Pierce L, Ben-David M, Vicini F, Hunt K . Recurrent cancer after breast-conserving surgery with radiation therapy for ductal carcinoma in situ: mammographic features, method of detection, and stage of recurrence. AJR Am J Roentgenol. 2007; 189(1):140-4. DOI: 10.2214/AJR.06.1281. View

10.

Wapnir I, Anderson S, Mamounas E, Geyer Jr C, Jeong J, Tan-Chiu E . Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in five National Surgical Adjuvant Breast and Bowel Project node-positive adjuvant breast cancer trials. J Clin Oncol. 2006; 24(13):2028-37. DOI: 10.1200/JCO.2005.04.3273. View

11.

van Dongen J, Voogd A, Fentiman I, LeGrand C, Sylvester R, Tong D . Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. J Natl Cancer Inst. 2000; 92(14):1143-50. DOI: 10.1093/jnci/92.14.1143. View

12.

Whelan T, Clark R, Roberts R, Levine M, Foster G . Ipsilateral breast tumor recurrence postlumpectomy is predictive of subsequent mortality: results from a randomized trial. Investigators of the Ontario Clinical Oncology Group. Int J Radiat Oncol Biol Phys. 1994; 30(1):11-6. DOI: 10.1016/0360-3016(94)90513-4. View

13.

Fisher B, Anderson S, Fisher E, Redmond C, Wickerham D, Wolmark N . Significance of ipsilateral breast tumour recurrence after lumpectomy. Lancet. 1991; 338(8763):327-31. DOI: 10.1016/0140-6736(91)90475-5. View

14.

Abner A, Recht A, Eberlein T, Come S, Shulman L, Hayes D . Prognosis following salvage mastectomy for recurrence in the breast after conservative surgery and radiation therapy for early-stage breast cancer. J Clin Oncol. 1993; 11(1):44-8. DOI: 10.1200/JCO.1993.11.1.44. View

15.

Orel S, Fowble B, Solin L, Schultz D, Conant E, Troupin R . Breast cancer recurrence after lumpectomy and radiation therapy for early-stage disease: prognostic significance of detection method. Radiology. 1993; 188(1):189-94. DOI: 10.1148/radiology.188.1.8511295. View

16.

Osako T, Takahashi K, Iwase T, Iijima K, Miyagi Y, Nishimura S . Diagnostic ultrasonography and mammography for invasive and noninvasive breast cancer in women aged 30 to 39 years. Breast Cancer. 2007; 14(2):229-33. DOI: 10.2325/jbcs.891. View

17.

Fisher B, Anderson S, Bryant J, Margolese R, Deutsch M, Fisher E . Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002; 347(16):1233-41. DOI: 10.1056/NEJMoa022152. View

18.

Voogd A, van Tienhoven G, Peterse H, Crommelin M, Rutgers E, van de Velde C . Local recurrence after breast conservation therapy for early stage breast carcinoma: detection, treatment, and outcome in 266 patients. Dutch Study Group on Local Recurrence after Breast Conservation (BORST). Cancer. 1999; 85(2):437-46. DOI: 10.1002/(sici)1097-0142(19990115)85:2<437::aid-cncr23>3.0.co;2-1. View

19.

Paulus D . Conservative treatment of breast cancer: mammography in patient selection and follow-up. AJR Am J Roentgenol. 1984; 143(3):483-7. DOI: 10.2214/ajr.143.3.483. View

20.

WINCHESTER D, Cox J . Standards for breast-conservation treatment. CA Cancer J Clin. 1992; 42(3):134-62. DOI: 10.3322/canjclin.42.3.134. View